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Introduction
Liver is the most important organ, which plays a pivotal role in regulating various physiological processes in the body. It is involved in several vital functions, such as metabolism, secretion and storage. It has great capacity to detoxicate toxic substances and synthesize useful principles. Therefore, damage to the liver inflicted by hepatotoxic agents is of grave consequences 1 . Liver diseases are mainly caused by toxic chemicals, excess consumption of alcohol, infections and autoimmune disorders. Most of the hepatotoxic chemicals damage liver cells mainly by inducing lipid peroxidation and other oxidative damages 2 . In addition, serum levels of many biochemical markers like aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and bilirubin were also elevated.
In spite of tremendous advances in modern medicine, there are not many effective drugs available that stimulate liver function, offer protection to the liver from damage or help to regenerate hepatic cells 3 . In the absence of reliable liver-protective drugs in modern medicine, there are a number of medicinal preparations in ayurveda recommended for the treatment of liver disorders 4 that have been in use for centuries which are quite often claimed to offer significant relief.
Limonia acidissima Linn syn Feronia limonia (Rutaceae) is a moderate sized deciduous tree grown throughout India. Its fruits are woody, rough and used as a substitute for bael in diarrhoea and dysentery while the bark and leaves are used for vitiated conditions of vata and pitta. The fruits are used for tumors, asthma, wounds, cardiac debility and hepatitis 5 . It has been reported that this part of the plant contains flavanoids, glycosides, saponins, tannins 6 , coumarins 7 and tyramine derivatives 8 . Fruit shells of L. acidissima have been reported to have antifungal compounds namely psoralene, xanthotoxin, 2,6-dimethoxybenzoquinone and osthenol 9 while the leaves have hepatoprotective activity 10. The stem bark of the plant yielded (-) -(2S) -5, 3' -dihydroxy-4'-methoxy-6",6"-dimemethylchromeno-(7, 8, 2",3")-flavanone along with several known compounds including an alkaloid, five coumarins, a flavanone, a lignan, three sterols and a triterpene which were found to possess antimicrobial activity 11 .
In spite of the medicinal claim for the fruit as a hepatoprotective, there are no reports in the literature regarding this pharmacological effect use as a hepatoprotective agent. Thus the present study was performed to evaluate the hepatoprotective activity of the methanolic extract of L. acidissima fruit pulp against CCl 4 -induced hepatic injury in rats.
Materials and Methods

Plant Materials
Fruits of L. acidissima were purchased from local market in Chennai in August 2007, separated into pulp and shell, and authenticated by Prof P. Jayaraman, a botanist at Plant Anatomy Research Centre (PARC), Tambaram, Chennai. A voucher specimen (SRMCP/08/07) was deposited in the Department of Pharmacognosy, SRM College of Pharmacy for future reference. The fruit pulp was shade dried, coarsely powdered using a cutter mill and stored in an air-tight, light resistant container for further use.
Preparation of extract
The coarsely powdered fruit pulp was defatted with hexane using soxhlet apparatus. The defatted material was further extracted with methanol using soxhlet apparatus and the extract obtained was concentrated using rotary evaporator and the extractive value, found to be 23% w/w, was then stored in a vacuum desiccator. 
Acute toxicity studies
Acute oral toxicity of MELA was determined using nulliparous, non-pregnant female mice. Albino mice were fasted for 3 hr prior to the experiment and were administered single dose of MELA dissolved in water and observed for mortality up to 48 hr. Based on the short term toxicity, the dose of the test animals were determined as per OECD guidelines 425. All the animals were observed for lethal or toxic signs up to 2000 mg/kg.
Study design
The animals were randomly divided into five groups consisting of six animals each: group I served as control and received double distilled water orally for 10 days; group II received CCl 4 0.5 ml/kg i.p. for 3 days; group III received Silymarin 13 100 mg/kg p.o for 10 days while groups IV and V received MELA at the dose of 200 and 400 mg/ kg p.o for 10 days, respectively.
Hepatoprotective activity
The rats were kept overnight fasting after 10 days and blood samples were collected by retro orbital puncture under ether anesthesia and the serum was used for the estimation of biochemical markers like AST, ALT 14 , ALP 15 and bilirubin 16 using standard kits 17 . The enzyme levels were assayed using standard kits from Erba Diagnostics, Germany and the results were expressed as U/l. The animal livers were dissected out and washed immediately with ice cold saline to remove blood and the wet weight noted. Liver homogenates were prepared in cold 50 mM potassium phosphate buffer pH 7.4 using Remi homogenizer. The unbroken cells and debris were removed by centrifugation at 2000 rpm for 10 min using a Remi cooling centrifuge and the supernatant was used for the estimation of GSH, SOD 18 , CAT 19 , TP 20 , GGT levels 21 .
Histopathological studies
The liver tissues were dissected out, washed with normal saline and fixed in 10% formalin. Paraffin sections were prepared and stained with haematoxylin and eosin and examined using light microscopy (x100 magnification).
Statistical analysis
The data are expressed as mean±SEM (n=6). Statistical significance was determined by one way ANOVA followed by Dunnet's test. At 95% confidence interval, p values less than 0.05 were considered significant.
Results
Acute toxicity
The methanolic extract of the fruit pulp was found to be non-toxic up to the dose of 2000 mg/kg. There was a significant (p< 0.05) increase in the serum hepatic enzyme levels in the group after CCl 4 treatment which was prevented by MELA and indicative of a decrease in serum marker enzyme levels (Table 1) (Figure 1b) . Concurrent administration of MELA preserved the histological structure of the liver though there was a mild congestion and regeneration of liver tissues (Figure 1c and 1d) .
In vivo lipid peroxidation
The effect of MELA on localization of radical formation resulting in lipid peroxidation is shown in Table 2 . LPO content in the liver homogenate was significantly increased in CCl 4 treated group when compared to normal group (p< 0.001). LPO level of MELA 200 and 400 mg/kg and Silymarin treated groups were significantly inhibited by 40%, 90% and 96%, respectively, when compared to the control group.
Effect of MELA on anti-oxidant enzyme levels
Effect of MELA on GSH, SOD and CAT of liver homogenate is shown in the Table 2 . The antioxidant enzyme levels in normal control group were observed to be significantly higher than CCl 4 control group. Antioxidant enzyme levels of MELA 200 and 400 mg/kg group were significantly increased by 45 and 90%, respectively, when compared to CCl 4 treated group and Silymarin treated group almost restored the enzyme levels.
Discussion
Carbon tetrachloride is the most commonly used hepatotoxin in the experimental study of liver diseases 22 . The hepatotoxic effects of CCl 4 are largely due to its active metabolite, 23 . In the assessment of liver damage by CCl 4 , hepatotoxin (the determination of enzyme levels such as AST and ALT) is largely used. This is evidenced by an elevation in the serum marker enzymes namely AST, ALP and ALT. At the two dose levels (200 and 400 mg/kg), the significant reduction of the enzyme levels in a dose dependant manner and increase in the level of TP by MELA indicate hepatoprotective activity as stimulation of protein synthesis accelerates the regeneration process and production of liver cells.
In the present study, elevation in the levels of antioxidant enzymes in CCl 4 treated animal was observed when compared to control group. Increase in GSH, CAT, SOD, LPO levels in the liver homogenates of CCl 4 treated group suggests enhanced lipid peroxidation leading to tissue damage and failure of antioxidant defense mechanisms. Treatment with MELA significantly prevented these changes and this may be due to its antioxidant effects. Since MELA treated groups has significantly elevated the GSH, SOD, CAT contents of the liver, it may also be helpful in treating the hepatotoxicity induced by other agents.
Estimation of γ-GTP levels is a valuable parameter with a high negative predictive value for liver diseases 24 . The γ-GTP levels increase proportionately with the increase in microsomal enzymes 25 . There is usually a severe damage to tissue membrane at CCl 4 toxic doses because γ-GTP is a membrane bound enzyme. But the γ-GTP levels have significantly decreased in MELA treated groups as shown in the Table 1 which is indicative of the membrane stabilizing activity of MELA in improvement of liver function.
Histopathological studies has shown that the pretreatment with MELA exhibited protection against CCl 4 induced fatty degeneration and necrosis of the liver tissue, confirming the results of biochemical studies and indicating the hepatoprotective properties of MELA..
Conclusion
Our results indicate that MELA exhibits significant dose dependant protective effect against CCl 4 -induced liver damage which may be due to its anti-lipid peroxidative and free radical scavenging properties. Further studies are in progress to isolate and identify the active principle involved in the hepatopro-tective and antioxidant activities of this plant extract. 
